BIOTRICITY INC. (BTCY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue Quarterly

0 1.5M 3M 4.5M Q2 '22: 1.8M Q3 '22: 1.9M Q4 '22: 2.1M Q1 '23: 2.1M Q2 '23: 2.4M Q3 '23: 2.5M Q4 '23: 2.7M Q1 '24: 3M Q2 '24: 2.9M Q3 '24: 3M Q4 '24: 3.2M Q1 '25: 3.2M Q2 '25: 3.3M Q3 '25: 3.6M Q4 '25: 3.7M Q1 '26: 3.9M Q2 '26: 3.9M Q3 '26: 4M Q4 '26: 4.3M Q1 '27: 4.3M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Gross Profit Quarterly

0 1.5M 3M 4.5M Q2 '22: 1.1M Q3 '22: 824.8K Q4 '22: 1.4M Q1 '23: 1.2M Q2 '23: 1.3M Q3 '23: 1.4M Q4 '23: 1.5M Q1 '24: 1.9M Q2 '24: 2M Q3 '24: 2.2M Q4 '24: 2.3M Q1 '25: 2.4M Q2 '25: 2.5M Q3 '25: 2.8M Q4 '25: 3M Q1 '26: 3.1M Q2 '26: 3.2M Q3 '26: 3.3M Q4 '26: 3.4M Q1 '27: 3.5M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Operating Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '22: -4.7M Q4 '22: -3.8M Q1 '23: -4.1M Q2 '23: -4M Q3 '23: -3.8M Q4 '23: -3.5M Q1 '24: -2.3M Q2 '24: -2.2M Q3 '24: -1.3M Q4 '24: -3M Q1 '25: -1.1M Q2 '25: -307.7K Q3 '25: -169K Q4 '25: -855.5K Q1 '26: 281.9K Q2 '26: 273.8K Q3 '26: 440.9K Q4 '26: 694.6K Q1 '27: 158.1K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Net Income Quarterly

-12M -8M -4M 0 4M 8M 12M Q2 '22: -10.8M Q3 '22: -7.1M Q4 '22: -5.6M Q1 '23: -4.8M Q2 '23: -4.7M Q3 '23: -4.5M Q4 '23: -4.7M Q1 '24: -3.4M Q2 '24: -3.7M Q3 '24: -2.8M Q4 '24: -4.2M Q1 '25: -3.7M Q2 '25: -1.6M Q3 '25: -1.2M Q4 '25: -1.9M Q1 '26: -672K Q2 '26: -690.9K Q3 '26: -717.1K Q4 '26: -324.2K Q1 '27: -959.5K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Cost of Revenue Quarterly

0 500K 1M 1.5M Q2 '22: 672.7K Q3 '22: 1.1M Q4 '22: 708.1K Q1 '23: 830.9K Q2 '23: 1.1M Q3 '23: 1.1M Q4 '23: 1.2M Q1 '24: 1.1M Q2 '24: 892K Q3 '24: 805K Q4 '24: 906K Q1 '25: 838.6K Q2 '25: 807.7K Q3 '25: 855.1K Q4 '25: 724.4K Q1 '26: 757.2K Q2 '26: 704.3K Q3 '26: 736.3K Q4 '26: 851.6K Q1 '27: 746.1K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q2 '22: -3.2M Q3 '22: -4.5M Q4 '22: -4.8M Q1 '23: -4M Q2 '23: -4.5M Q3 '23: -3.2M Q4 '23: -1.9M Q1 '24: -1.8M Q2 '24: -2.4M Q3 '24: -1.3M Q4 '24: -1.2M Q1 '25: -1.5M Q2 '25: -397.1K Q3 '25: -88.1K Q4 '25: -400.8K Q1 '26: -373.4K Q2 '26: 415.6K Q3 '26: -740.3K Q4 '26: -20.9K Q1 '27: 507.2K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q4 '22: -4.8M Q4 '22

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '22: 39.1M Q2 '22: 42.9M Q3 '22: 49.2M Q1 '23: 51.4M Q2 '23: 8.6M Q3 '23: 8.7M Q1 '24: 8.8M Q2 '24: 8.8M Q3 '24: 9M Q1 '25: 14.2M Q2 '25: 22.5M Q3 '25: 24.2M Q1 '26: 26.3M Q2 '26: 26.8M Q3 '26: 27.6M Q1 '27: 23.1M Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.40 -1.60 -0.80 0.00 0.80 1.60 2.40 Q2 '22: -0.67 Q3 '22: -0.71 Q4 '22: -0.67 Q1 '23: -0.61 Q2 '23: -0.92 Q3 '23: -1.32 Q4 '23: -1.77 Q1 '24: -2.08 Q2 '24: -1.95 Q3 '24: -1.75 Q4 '24: -1.66 Q1 '25: -1.74 Q2 '25: -1.37 Q3 '25: -1.09 Q4 '25: -0.67 Q1 '26: -0.21 Q2 '26: -0.17 Q3 '26: -0.16 Q4 '26: -0.12 Q1 '27: -0.13 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.